81 FR 71109 - CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 81, Issue 199 (October 14, 2016)

Page Range		71109-71109
FR Document		2016-24807

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), notice is hereby given that a meeting is scheduled for the Centers for Disease Control and Prevention (CDC)/ HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. This meeting will be open to the public. Information about the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and the agenda for this meeting can be obtained by contacting LCDR Holly Berilla at (301) 443-9965 or [email protected]

Federal Register, Volume 81 Issue 199 (Friday, October 14, 2016)

[Federal Register Volume 81, Number 199 (Friday, October 14, 2016)]
[Notices]
[Page 71109]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-24807]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services, (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given that a meeting 
is scheduled for the Centers for Disease Control and Prevention (CDC)/
HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment. This meeting will be open to the public. Information about 
the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment and the agenda for this meeting can be 
obtained by contacting LCDR Holly Berilla at (301) 443-9965 or 
[email protected].

DATES: The meeting will be held on November 16, 2016, from 8:30 a.m. to 
5:00 p.m. and November 17, 2016, from 8:30 a.m. to 3:30 p.m.

ADDRESSES: This meeting will be held in-person and offer virtual access 
through teleconference and Adobe Connect. The address for the meeting 
is 5600 Fishers Lane, Rockville, Maryland 20857, Room 5A02 (Pavilion). 
Parties may access the teleconference by dialing 800-369-1193 and using 
the public participant code: 7050725. Parties may also access the 
meeting through Adobe Connect (visual only) by using the following URL: 
https://hrsa.connectsolutions.com/CHAC_1116.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment should contact LCDR Holly Berilla, Public 
Health Analyst, Division of Policy and Data (DPD), HIV/AIDS Bureau 
(HAB), HRSA, in one of three ways: (1) Send a request to the following 
address: LCDR Holly Berilla, Public Health Analyst, DPD, HAB, HRSA, 
5600 Fishers Lane, 09N164C, Rockville, Maryland 20857; (2) call 301-
443-9965; or (3) send an email to [email protected].

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service Act, [42 U.S.C. Section 217a], 
as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary, 
HHS; the Director, CDC; and the Administrator, HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV/AIDS, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional eduction, patient healthcare delivery, and prevention 
services; Agency policies about prevention of HIV/AIDS, viral hepatitis 
and other STDs; treatment, healthcare delivery, and research and 
training; strategic issues influencing the ability of CDC and HRSA to 
fulfill their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to the Agencies in their developoment of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs.
    During the November 16-17, 2016, meeting, the CDC/HRSA Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will 
discuss and deliberate on areas for evaluation by HRSA/HAB; expansion 
of national viral hepatitis programs; employment, housing, aging and 
leadership initiatives geared to people living with HIV/AIDS; and 
updates from Committee workgroups. Agenda items are subject to change 
as priorities dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment should be sent to LCDR 
Holly Berilla, using the address and phone number listed above by 
November 1, 2016. The building at 5600 Fishers Lane, Rockville, MD 
20857, requires a security screening on entry. To facilitate access to 
the building please contact LCDR Holly Berilla at the address and phone 
number listed above. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify LCDR Holly Berilla at the address and 
phone number listed above at least 10 days prior to the meeting.

Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-24807 Filed 10-13-16; 8:45 am]
 BILLING CODE 4165-15-P

Federal Register / Vol. 81, No. 199 / Friday, October 14, 2016 / Notices 71109

HRSA specifically requests comments regarding the CDC/HRSA Advisory comments will be honored in the order
on (1) the necessity and utility of the Committee on HIV, Viral Hepatitis and they are requested and may be limited
proposed information collection for the STD Prevention and Treatment should as time allows. Requests to make oral
proper performance of the agency’s contact LCDR Holly Berilla, Public comments or provide written comments
functions, (2) the accuracy of the Health Analyst, Division of Policy and to the CDC/HRSA Advisory Committee
estimated burden, (3) ways to enhance Data (DPD), HIV/AIDS Bureau (HAB), on HIV, Viral Hepatitis and STD
the quality, utility, and clarity of the HRSA, in one of three ways: (1) Send a Prevention and Treatment should be
information to be collected, and (4) the request to the following address: LCDR sent to LCDR Holly Berilla, using the
use of automated collection techniques Holly Berilla, Public Health Analyst, address and phone number listed above
or other forms of information DPD, HAB, HRSA, 5600 Fishers Lane, by November 1, 2016. The building at
technology to minimize the information 09N164C, Rockville, Maryland 20857; 5600 Fishers Lane, Rockville, MD
collection burden. (2) call 301–443–9965; or (3) send an 20857, requires a security screening on
email to hberilla@hrsa.gov. entry. To facilitate access to the building
Jason E. Bennett,
SUPPLEMENTARY INFORMATION: The CDC/ please contact LCDR Holly Berilla at the
Director, Division of the Executive Secretariat. address and phone number listed above.
HRSA Advisory Committee on HIV,
[FR Doc. 2016–24843 Filed 10–13–16; 8:45 am] Individuals who plan to attend and
Viral Hepatitis and STD Prevention and
BILLING CODE 4165–15–P
Treatment was established under need special assistance, such as sign
Section 222 of the Public Health Service language interpretation or other
Act, [42 U.S.C. Section 217a], as reasonable accommodations, should
DEPARTMENT OF HEALTH AND notify LCDR Holly Berilla at the address
HUMAN SERVICES amended.
The purpose of the CDC/HRSA and phone number listed above at least
Health Resources and Service Advisory Committee on HIV, Viral 10 days prior to the meeting.
Administration Hepatitis and STD Prevention and Jason E. Bennett,
Treatment is to advise the Secretary, Director, Division of the Executive Secretariat.
CDC/HRSA Advisory Committee on HHS; the Director, CDC; and the
[FR Doc. 2016–24807 Filed 10–13–16; 8:45 am]
HIV, Viral Hepatitis and STD Prevention Administrator, HRSA regarding
BILLING CODE 4165–15–P
and Treatment objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
AGENCY: Health Resources and Service other STDs; prevention and treatment
Administration (HRSA), Department of DEPARTMENT OF HEALTH AND
efforts including surveillance of HIV HUMAN SERVICES
Health and Human Services, (HHS). infection, AIDS, viral hepatitis, and
ACTION: Notice of meeting. other STDs, and related behaviors; National Institutes of Health
epidemiologic, behavioral, health
SUMMARY: In accordance with section
services, and laboratory research on National Institute on Deafness and
10(a)(2) of the Federal Advisory
HIV/AIDS, viral hepatitis, and other Other Communication Disorders;
Committee Act (Pub. L. 92–463), notice
STDs; identification of policy issues Notice of Closed Meeting
is hereby given that a meeting is
related to HIV/viral hepatitis/STD Pursuant to section 10(d) of the
scheduled for the Centers for Disease
professional eduction, patient Federal Advisory Committee Act, as
Control and Prevention (CDC)/HRSA
healthcare delivery, and prevention amended (5 U.S.C. App.), notice is
Advisory Committee on HIV, Viral
services; Agency policies about hereby given of the following meeting.
Hepatitis and STD Prevention and
prevention of HIV/AIDS, viral hepatitis The meeting will be closed to the
Treatment. This meeting will be open to
and other STDs; treatment, healthcare public in accordance with the
the public. Information about the CDC/
delivery, and research and training; provisions set forth in sections
HRSA Advisory Committee on HIV,
strategic issues influencing the ability of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Viral Hepatitis and STD Prevention and
CDC and HRSA to fulfill their missions as amended. The grant applications and
Treatment and the agenda for this
of providing prevention and treatment the discussions could disclose
meeting can be obtained by contacting
services; programmatic efforts to confidential trade secrets or commercial
LCDR Holly Berilla at (301) 443–9965 or
prevent and treat HIV, viral hepatitis, property such as patentable material,
hberilla@hrsa.gov.
and other STDs; and support to the and personal information concerning
DATES: The meeting will be held on Agencies in their developoment of
November 16, 2016, from 8:30 a.m. to individuals associated with the grant
responses to emerging health needs applications, the disclosure of which
5:00 p.m. and November 17, 2016, from related to HIV, viral hepatitis, and other
8:30 a.m. to 3:30 p.m. would constitute a clearly unwarranted
STDs. invasion of personal privacy.
ADDRESSES: This meeting will be held During the November 16–17, 2016,
in-person and offer virtual access meeting, the CDC/HRSA Advisory Name of Committee: National Institute on
through teleconference and Adobe Deafness and Other Communication
Committee on HIV, Viral Hepatitis and Disorders Special Emphasis Panel; U01
Connect. The address for the meeting is STD Prevention and Treatment will Clinical Trial Review.
5600 Fishers Lane, Rockville, Maryland discuss and deliberate on areas for Date: November 4, 2016.
20857, Room 5A02 (Pavilion). Parties evaluation by HRSA/HAB; expansion of Time: 2:00 p.m. to 3:30 p.m.
may access the teleconference by dialing national viral hepatitis programs; Agenda: To review and evaluate grant
800–369–1193 and using the public employment, housing, aging and applications.
rmajette on DSK2TPTVN1PROD with NOTICES

participant code: 7050725. Parties may leadership initiatives geared to people Place: National Institutes of Health
also access the meeting through Adobe living with HIV/AIDS; and updates from Neuroscience Center, 6001 Executive
Connect (visual only) by using the Boulevard, Rockville, MD 20852, (Telephone
Committee workgroups. Agenda items Conference Call).
following URL: https:// are subject to change as priorities Contact Person: Kausik Ray, Ph.D.,
hrsa.connectsolutions.com/CHAC_1116. dictate. Scientific Review Officer, National Institute
FOR FURTHER INFORMATION CONTACT: Members of the public will have the on Deafness and Other Communication
Anyone requesting information opportunity to provide comments. Oral Disorders, National Institutes of Health,

VerDate Sep<11>2014 14:29 Oct 13, 2016 Jkt 241001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\14OCN1.SGM 14OCN1

Document Created: 2016-10-14 00:01:27
Document Modified: 2016-10-14 00:01:27

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on November 16, 2016, from 8:30 a.m. to 5:00 p.m. and November 17, 2016, from 8:30 a.m. to 3:30 p.m.
Contact		Anyone requesting information regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment should contact LCDR Holly Berilla, Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS Bureau (HAB), HRSA, in one of three ways: (1) Send a request to the following
FR Citation		81 FR 71109

81 FR 71109 - CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Services Administration

Federal Register Volume 81, Issue 199 (October 14, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration